Dana Hilt

Dana Hilt

Direttore Tecnico/Scientifico/R&S presso ACTINOGEN MEDICAL LIMITED
73 anni
Health Technology
Consumer Services

Profilo

Dana Charles Hilt is currently Chief Medical Officer at Actinogen Medical Ltd. since 2023.
Former positions include Director-Clinical Neurosciences at Amgen, Inc., Vice President-Clinical Research at Guilford Pharmaceuticals, Inc., Chief Medical Officer at Critical Therapeutics, Inc. from 2006 to 2007, Chief Medical Officer & SVP-Drug Development at FORUM Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Research at Ascend Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Research at ASCEND Therapeutics US LLC, Chief Medical Officer at Lysosomal Therapeutics, Inc. from 2016 to 2019, Chief Medical Officer at Frequency Therapeutics, Inc., and Chief Medical Officer at Brenig Therapeutics, Inc. Education includes undergraduate studies at the University of Maine and a doctorate from Tufts University School of Medicine.

Posizioni attive di Dana Hilt

SocietàPosizioneInizio
ACTINOGEN MEDICAL LIMITED Direttore Tecnico/Scientifico/R&S 01/02/2023

Precedenti posizioni note di Dana Hilt

SocietàPosizioneFine
Direttore Tecnico/Scientifico/R&S 10/06/2025
Direttore Tecnico/Scientifico/R&S 01/08/2019
Direttore Tecnico/Scientifico/R&S 25/09/2007
Direttore Tecnico/Scientifico/R&S -
KORRO BIO, INC. Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di Dana Hilt

Formazione di Dana Hilt

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

11

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Ascend Pharmaceuticals, Inc.

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA